ImmunityBio, Inc. (FRA:26CA)
Germany
· Delayed Price · Currency is EUR 1.964
+0.104 (5.59%)
At close: Dec 4, 2025
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of €1.94 billion as of December 5, 2025. Its market cap has decreased by -41.30% in one year.
Market Cap
1.94B
Enterprise Value
2.46B
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.96
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from 12.47B to 1.94B, a decrease of -84.45%. That is a compound annual growth rate of -32.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.94B | 7.59% |
| Dec 31, 2024 | 1.81B | -40.46% |
| Dec 29, 2023 | 3.03B | 56.14% |
| Dec 30, 2022 | 1.94B | -8.68% |
| Dec 31, 2021 | 2.13B | -82.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 244.97B |
| Siemens Aktiengesellschaft | 177.09B |
| Allianz SE | 138.86B |
| Deutsche Telekom AG | 129.48B |
| Siemens Energy AG | 99.77B |
| Rheinmetall AG | 69.69B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.64B |
| Deutsche Bank Aktiengesellschaft | 58.94B |